129 related articles for article (PubMed ID: 10682270)
1. Immunohistochemical detection of lactoferrin in human astrocytomas and multiforme glioblastomas.
Tuccari G; Giuffrè G; Crisafulli C; Barresi G
Eur J Histochem; 1999; 43(4):317-22. PubMed ID: 10682270
[TBL] [Abstract][Full Text] [Related]
2. Ras p21 expression in brain tumors: elevated expression in malignant astrocytomas and glioblastomas multiforme.
Arvanitis D; Malliri A; Antoniou D; Linardopoulos S; Field JK; Spandidos DA
In Vivo; 1991; 5(4):317-21. PubMed ID: 1667267
[TBL] [Abstract][Full Text] [Related]
3. Annexin II marks astrocytic brain tumors of high histologic grade.
Roseman BJ; Bollen A; Hsu J; Lamborn K; Israel MA
Oncol Res; 1994; 6(12):561-7. PubMed ID: 7787249
[TBL] [Abstract][Full Text] [Related]
4. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
5. Nucleolar organizer regions (AgNORs) in astrocytic tumors.
Pedal WP; Warzok RW; Hufnagl P; Roth K
Zentralbl Pathol; 1994 Mar; 140(1):89-94. PubMed ID: 7515679
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
[TBL] [Abstract][Full Text] [Related]
7. Expression of Fas/APO-1 during the progression of astrocytomas.
Tachibana O; Nakazawa H; Lampe J; Watanabe K; Kleihues P; Ohgaki H
Cancer Res; 1995 Dec; 55(23):5528-30. PubMed ID: 7585627
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Varakis I
Anticancer Res; 1997; 17(4A):2677-82. PubMed ID: 9252700
[TBL] [Abstract][Full Text] [Related]
9. [Expression of glial fibrillary acidic protein and protein S-100 in cerebral astrocytic gliomas of varying degrees of malignancy (immunohistochemical study)].
Korshunov AG; Sycheva RV
Arkh Patol; 1995; 57(4):30-8. PubMed ID: 8526753
[TBL] [Abstract][Full Text] [Related]
10. Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis.
Mikkelsen T; Yan PS; Ho KL; Sameni M; Sloane BF; Rosenblum ML
J Neurosurg; 1995 Aug; 83(2):285-90. PubMed ID: 7542317
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors.
Broholm H; Laursen H
APMIS; 2004; 112(4-5):257-63. PubMed ID: 15233640
[TBL] [Abstract][Full Text] [Related]
12. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2).
Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M
Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
[TBL] [Abstract][Full Text] [Related]
14. Proteomic studies on low- and high-grade human brain astrocytomas.
Odreman F; Vindigni M; Gonzales ML; Niccolini B; Candiano G; Zanotti B; Skrap M; Pizzolitto S; Stanta G; Vindigni A
J Proteome Res; 2005; 4(3):698-708. PubMed ID: 15952716
[TBL] [Abstract][Full Text] [Related]
15. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
Reilly KM; Loisel DA; Bronson RT; McLaughlin ME; Jacks T
Nat Genet; 2000 Sep; 26(1):109-13. PubMed ID: 10973261
[TBL] [Abstract][Full Text] [Related]
16. Microtubule-associated protein 2 (MAP-2) is expressed in low and high grade diffuse astrocytomas.
Wharton SB; Chan KK; Whittle IR
J Clin Neurosci; 2002 Mar; 9(2):165-9. PubMed ID: 11922706
[TBL] [Abstract][Full Text] [Related]
17. Changes of the bromodeoxyuridine labeling index of astrocytic tumors between primary and recurrent lesions.
Tamura M; Ono N; Zama A; Kurihara H
Noshuyo Byori; 1994; 11(2):173-6. PubMed ID: 7894621
[TBL] [Abstract][Full Text] [Related]
18. Assessment of protein conformation in human benign and malignant astrocytomas by reflectance Fourier transform infrared microspectroscopy.
Lee LS; Chi CW; Liu HC; Cheng CL; Li MJ; Lin SY
Oncol Res; 1998; 10(1):23-7. PubMed ID: 9613454
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion.
Suzuki T; Izumoto S; Fujimoto Y; Maruno M; Ito Y; Yoshimine T
J Clin Pathol; 2005 Feb; 58(2):166-71. PubMed ID: 15677537
[TBL] [Abstract][Full Text] [Related]
20. Labeling and quantitative analysis of six lectin receptors of intracranial gliomas.
Yang S; Liu Z; Zhu Y; Chen X
Chin Med J (Engl); 1995 Jan; 108(1):37-43. PubMed ID: 7712837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]